Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

by Calverley PMA, Tetzlaff K, Dusser D, Wise RA, Mueller A, Metzdorf N, Anzueto A
Published 2017-11-01

Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease

by Krachunov Iliya, Kyuchukov Nikolay, Ivanova Zlatina, Yanev Nikolay A., Hristova Petkana A., Pavlov Plamen, Glogovska Pavlina, Popova Tsanya, Ivanov Yavor Y.
Published 2018-12-01

REQUENT EXACERBATORS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FROM RESEARCH TO CLINICAL PRACTICE

by Richard Hewitt, Patrick Mallia
Published 2015-05-01

Frailty, a Dimension of Impaired Functional Status in Advanced COPD: Utility and Clinical Applicability

by Sabina Antonela Antoniu, Lucian Vasile Boiculese, Virgiliu Prunoiu
Published 2021-05-01

Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations

by Cheng YS, Tu XW, Pan LL, Lu S, Xing M, Li LL, Chen XW
Published 2017-07-01

Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators

by Lu FY, Chen R, Li N, Sun XW, Zhou M, Li QY, Guo Y
Published 2021-02-01

Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations

by Lin CM, Yang TM, Yang YH, Tsai YH, Lee CP, Chen PC, Chen WC, Hsieh MJ
Published 2020-02-01

Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization

by Dilektasli AG, Demirdogen Cetinoglu E, Uzaslan E, Budak F, Coskun F, Ursavas A, Ercan I, Ege E
Published 2017-01-01

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype

by Miłkowska-Dymanowska J, Białas AJ, Szewczyk K, Kurmanowska Z, Górski P, Piotrowski WJ
Published 2018-11-01

Airway bacterial and fungal microbiome in chronic obstructive pulmonary disease

by Haiyue Liu, Zhenyu Liang, Nannan Cao, Xinzhu Yi, Xilan Tan, Zuheng Liu, Fengyan Wang, Yuqiong Yang, Chunxi Li, Zhiming Xiang, Yan He, Jin Su, Zhang Wang, Rongchang Chen, Hongwei Zhou
Published 2021-03-01

Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain

by Alcázar-Navarrete B, García-Rio F, Sánchez G, Mariscal E, García A, Cuesta M, Uría E, Miravitlles M
Published 2021-07-01

COPD, stage and treatment in a large outpatient clinic

by Claire Præst Holm, Jakob Holm, Annette Nørgaard, Nina Godtfredsen
Published 2017-01-01

AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD

by Rui Ye, Cuihong Wang, Pengbo Sun, Shuang Bai, Li Zhao
Published 2021-06-01

Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014

by Josefin Sundh, Joakim Åberg, Mikael Hasselgren, Scott Montgomery, Björn Ställberg, Karin Lisspers, Christer Janson
Published 2017-01-01

Carbocisteine lysine salt in the treatment of patients with chronic obstructive pulmonary disease with frequent exacerbations

by D. S. Tyrtov, E. I. Shmelev
Published 2014-12-01